ESSA Pharma's market cap is currently $77.68M. The company's EPS TTM is $-0.701; its P/E ratio is ―; ESSA Pharma is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ -118.49K	$ -121.79K	$ -109.46K	$ -110.32K
Operating Income	$ 0.00	$ -32.13M	$ -35.34M	$ -36.91M	$ -23.12M
EBITDA	$ 0.00	$ -26.46M	$ -35.08M	$ -36.71M	$ -23.01M
Net Income	$ 0.00	$ -26.58M	$ -35.10M	$ -36.81M	$ -23.45M
Balance Sheet
Cash & Short-Term Investments	$ 126.76M	$ 148.08M	$ 57.08M	$ 194.93M	$ 56.32M
Total Assets	$ 128.11M	$ 149.12M	$ 169.50M	$ 198.17M	$ 80.58M
Total Debt	$ 329.26K	$ 80.33K	$ 209.83K	$ 330.97K	$ 59.09K
Net Debt	$ -103.38M	$ -33.62M	$ -56.87M	$ -137.49M	$ -56.26M
Total Liabilities	$ 3.51M	$ 3.50M	$ 2.39M	$ 4.16M	$ 1.33M
Stockholders' Equity	$ 128.11M	$ 145.63M	$ 167.12M	$ 194.01M	$ 79.24M
Cash Flow
Free Cash Flow	$ -22.72M	$ -19.78M	$ -28.70M	$ -25.42M	$ -16.98M
Operating Cash Flow	$ -22.72M	$ -19.78M	$ -28.70M	$ -25.42M	$ -16.98M
Investing Cash Flow	$ 91.79M	$ -3.53M	$ -52.35M	$ -35.01M	$ -21.74M
Financing Cash Flow	$ 925.51K	$ -68.16K	$ 252.74K	$ 141.99M	$ 41.78M

Currency in USD

ESSA Pharma Earnings and Revenue History

Income Statement >

ESSA Pharma Debt to Assets

Balance Sheet >

ESSA Pharma Cash Flow

Cash Flow >

ESSA Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing